急性期用脳室ドレーン市場- 世界の産業規模、シェア、動向、機会、予測、用途別、患者タイプ別、地域別、競合別セグメント、2020-2030F

急性期用脳室ドレーンの世界市場は、2024年に2億5,234万米ドルとなり、2030年までのCAGRは5.40%で、予測期間中に目覚ましい成長を遂げると予測されています。

世界のヘルスケア業界では、脳神経外科手術やデバイスの需要が着実に増加しており、頭蓋内疾患の患者管理に極めて重要な役割を果たす重要なデバイスの1つが急性期用脳室ドレーン（EVD）です。EVDは、脳脊髄液（CSF）レベルや頭蓋内圧（ICP）のモニタリングや管理、さまざまな神経外科手術の補助に欠かせないツールです。世界の急性期用脳室ドレーン市場はここ数年大きな成長を遂げており、今後も上昇基調が続くと予想されます。

市場促進要因

神経疾患の発生率の増加

主な市場課題

規制遵守と品質保証

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 急性期用脳室ドレーン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（外傷性脳損傷（TBI）、くも膜下出血、脳内出血、その他）
  • 患者タイプ別（小児、成人）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の急性期用脳室ドレーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の急性期用脳室ドレーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の急性期用脳室ドレーン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の急性期用脳室ドレーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの急性期用脳室ドレーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の急性期用脳室ドレーン市場：SWOT分析

第14章 競合情勢

• Medtronic plc
• Integra LifeSciences Corporation
• Natus Medical Incorporated
• Fuji Systems Corporation
• Spiegelberg GmbH
• SOPHYSA inc.
• Neuromedex inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Acute External Ventricular Drain Market was valued at USD 252.34 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.40% through 2030. The global healthcare industry has been witnessing a steady rise in the demand for neurosurgical procedures and devices, and one such critical device that plays a pivotal role in the management of patients with intracranial conditions is the Acute External Ventricular Drain (EVD). EVDs are indispensable tools for monitoring and managing cerebrospinal fluid (CSF) levels, intracranial pressure (ICP), and assisting in various neurosurgical procedures. The global Acute External Ventricular Drain market has been experiencing significant growth over the past few years and is expected to continue its upward trajectory.

Key Market Drivers

Rising Incidence of Neurological Disorders

The Global Acute External Ventricular Drain (EVD) Market has been experiencing steady growth in recent years, driven by a combination of factors that reflect the increasing prevalence of neurological disorders, advancements in medical technology, and a growing aging population. In 2021, over 3 billion individuals globally were affected by neurological conditions, underscoring a significant and growing healthcare challenge. The World Health Organization (WHO) played an active role in interpreting data from the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021, offering critical insights to inform strategic healthcare planning and investment decisions across both public and private sectors. EVD is a crucial medical device used in the management of conditions like hydrocephalus, traumatic brain injuries, and intracranial hemorrhage. In 2019, traumatic brain injury (TBI) accounted for 27.16 million new cases globally, with 48.99 million individuals living with the condition and 7.08 million years lived with disability (YLDs). In parallel, spinal cord injury (SCI) recorded 0.91 million new cases, 20.64 million prevalent cases, and 6.20 million YLDs. One of the primary drivers of the Global Acute EVD Market is the increasing incidence of neurological disorders worldwide. Neurological conditions, such as hydrocephalus, which involves the accumulation of cerebrospinal fluid in the brain, often require surgical intervention, including the use of EVDs. Additionally, traumatic brain injuries and intracranial hemorrhages, which can result from accidents or falls, necessitate immediate medical attention, leading to an increased demand for EVDs.

Key Market Challenges

Regulatory Compliance and Quality Assurance

One of the primary challenges in the EVD market is ensuring compliance with rigorous regulatory requirements and maintaining high-quality standards. These devices are critical for patient safety, and any flaws in design, manufacturing, or usage can have severe consequences. Manufacturers must adhere to strict guidelines set by regulatory bodies like the FDA and CE (Conformite Europeene) in Europe. Ensuring compliance while striving for innovation is a delicate balance that EVD companies must navigate.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed remarkable transformations in recent years, largely driven by technological advancements that have revolutionized patient care, diagnosis, and treatment. One area where these advancements are making a significant impact is in the field of neurosurgery and critical care. The Global Acute External Ventricular Drain (EVD) Market is experiencing substantial growth due to the integration of cutting-edge technologies, making it an integral component of modern medical practice. Recent advancements in material science and engineering have led to the development of smaller, lightweight, and biocompatible EVD devices. Miniaturized EVDs offer several benefits, including reduced infection risk, ease of placement, and patient comfort. Additionally, these devices are less obtrusive, making them more patient-friendly while providing healthcare professionals with enhanced monitoring capabilities.

Wireless technology has brought a new dimension to EVD management. Modern EVD systems are equipped with wireless sensors and connectivity options that allow real-time monitoring and remote data access. This enables healthcare providers to closely monitor patients' ICP and CSF pressure without being physically present, making it especially valuable in telemedicine and remote patient management scenarios. Artificial intelligence (AI) and machine learning algorithms have made significant inroads in healthcare, including the neurosurgical field. AI-powered EVD systems can analyze vast amounts of data, providing insights into trends and patterns in ICP and CSF pressure. This data-driven approach allows for more precise prediction of critical events and timely interventions, potentially saving lives and improving patient outcomes. Infections associated with EVDs have been a long-standing concern. However, technological advancements have led to the development of EVDs with enhanced infection control features. Antimicrobial-coated catheters, closed drainage systems, and sterile insertion techniques have significantly reduced the risk of infections associated with EVD placement, improving patient safety.

Key Market Players

• Medtronic plc
• Integra LifeSciences Corporation
• Natus Medical Incorporated
• Fuji Systems Corporation
• Spiegelberg GmbH
• SOPHYSA inc.
• Neuromedex inc.

Report Scope:

In this report, the Global Acute External Ventricular Drain Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Acute External Ventricular Drain Market, By Application:

• Traumatic Brain Injury (TBI)
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Others

Acute External Ventricular Drain Market, By Patient Type:

• Pediatric
• Adult

Acute External Ventricular Drain Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Acute External Ventricular Drain Market.

Available Customizations:

Global Acute External Ventricular Drain market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Acute External Ventricular Drain Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Traumatic Brain Injury (TBI), Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Others)
  • 5.2.2. By Patient Type (Pediatric, Adult)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Acute External Ventricular Drain Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Patient Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Acute External Ventricular Drain Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Patient Type
  • 6.3.2. Canada Acute External Ventricular Drain Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Patient Type
  • 6.3.3. Mexico Acute External Ventricular Drain Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Patient Type

7. Europe Acute External Ventricular Drain Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Patient Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Acute External Ventricular Drain Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Patient Type
  • 7.3.2. United Kingdom Acute External Ventricular Drain Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Patient Type
  • 7.3.3. Italy Acute External Ventricular Drain Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Patient Type
  • 7.3.4. France Acute External Ventricular Drain Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Patient Type
  • 7.3.5. Spain Acute External Ventricular Drain Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Patient Type

8. Asia-Pacific Acute External Ventricular Drain Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Patient Type
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Acute External Ventricular Drain Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Patient Type
  • 8.3.2. India Acute External Ventricular Drain Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Patient Type
  • 8.3.3. Japan Acute External Ventricular Drain Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Patient Type
  • 8.3.4. South Korea Acute External Ventricular Drain Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Patient Type
  • 8.3.5. Australia Acute External Ventricular Drain Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Patient Type

9. South America Acute External Ventricular Drain Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Patient Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Acute External Ventricular Drain Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Patient Type
  • 9.3.2. Argentina Acute External Ventricular Drain Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Patient Type
  • 9.3.3. Colombia Acute External Ventricular Drain Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Patient Type

10. Middle East and Africa Acute External Ventricular Drain Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Patient Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Acute External Ventricular Drain Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Patient Type
  • 10.3.2. Saudi Arabia Acute External Ventricular Drain Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Patient Type
  • 10.3.3. UAE Acute External Ventricular Drain Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Patient Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Acute External Ventricular Drain Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Medtronic plc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Integra LifeSciences Corporation
• 14.3. Natus Medical Incorporated
• 14.4. Fuji Systems Corporation
• 14.5. Spiegelberg GmbH
• 14.6. SOPHYSA inc.
• 14.7. Neuromedex inc.

15. Strategic Recommendations

16. About Us & Disclaimer